Cite

    Gong, J. et al. (2018). Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade. Clinical and translational medicine. 7 (1), p. n/a. [Online].